Related Experiment Video
Updated: Dec 11, 2025
12:40
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
10.6K
Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and
Alain H Litwin1,2,3, Laura Shafner4, Brianna Norton5
1Department of Medicine, University of South Carolina School of Medicine-Greenville, Greenville, South Carolina, USA.
Open Forum Infectious Diseases
|August 21, 2020
Summary
This study shows high treatment adherence and sustained virologic response in people who inject drugs with hepatitis C virus infection, utilizing an artificial intelligence platform for health outcome evaluation.
Area of Science:
- Hepatology
- Infectious Diseases
- Artificial Intelligence in Medicine
Background:
- Hepatitis C virus (HCV) infection disproportionately affects people who inject drugs (PWID).
- Effective treatment adherence is crucial for achieving sustained virologic response (SVR) in HCV-infected individuals.
- Monitoring adherence and health outcomes in PWID presents unique challenges.
Purpose of the Study:
- To evaluate health outcomes, specifically treatment adherence and SVR rates, in people who inject drugs (PWID) with hepatitis C virus (HCV) infection.
- To assess the utility of an artificial intelligence (AI) platform in monitoring these health outcomes.
- To identify factors influencing treatment success in this population.
Main Methods:
- A cohort of people who inject drugs (PWID) infected with hepatitis C virus (HCV) was studied.
- An artificial intelligence (AI) platform was employed to monitor health outcomes and treatment adherence.
- Cumulative adherence was assessed via visual confirmation of drug administration.
Main Results:
- Mean cumulative adherence to treatment was 91.3% (SD 10.5%).
- A high proportion of subjects, 88.2%, achieved ≥80% adherence.
- Notably, 88.2% (15 of 17) of participants achieved a sustained virologic response (SVR).
Conclusions:
- High treatment adherence and sustained virologic response (SVR) rates are achievable in people who inject drugs (PWID) with hepatitis C virus (HCV) infection.
- Artificial intelligence (AI) platforms show promise in monitoring and supporting treatment adherence and outcomes in this population.
- These findings underscore the effectiveness of current HCV treatment regimens even in challenging populations like PWID.
Related Concept Videos
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
71
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
71
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
102
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
102
01:29Subviral Agents
359
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
359
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
131
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
131
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
106
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
106
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
160
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
160